Norris Medicines Ltd — Important, 20-04-2026: Company Update

Norris Medicines has filed a compliance certificate from its Registrar & Transfer Agent for the quarter ended March. The certificate confirms that all shares received for dematerialisation were properly processed, accepted or rejected, and subsequently listed on stock exchanges. It also assures that physical share certificates were mutilated and cancelled after due verification, with depository names correctly updated in the register of members within required timelines. This filing confirms robust adherence to share transfer and record-keeping processes, ensuring smooth operations for shareholders converting physical shares to demat.